# Bilateral Facial Nerve Palsy Revealing Diffuse Large B-Cell Lymphoma With Leptomeningeal Involvement

**Authors:** Al Motasim Bella Abu Laban, Waleed Muhammad, Nabih Hanbali

PMC · DOI: 10.7759/cureus.86828 · 2025-06-26

## TL;DR

A rare case of brain lymphoma presented as facial nerve palsy, highlighting the need for early imaging and spinal fluid tests to detect serious conditions.

## Contribution

This case report highlights a rare presentation of CNS lymphoma mimicking Bell’s palsy and emphasizes the diagnostic value of neuroimaging and CSF analysis.

## Key findings

- Bilateral facial nerve palsy was linked to leptomeningeal lymphoma, not idiopathic Bell’s palsy.
- Neuroimaging and CSF analysis confirmed CNS lymphoma with marrow and nerve root involvement.
- Early diagnosis through imaging and spinal fluid tests enabled timely chemotherapy initiation.

## Abstract

We present a diagnostically challenging case of a 54-year-old woman who developed progressive bilateral lower motor neuron (LMN) facial nerve palsy, later accompanied by lower limb weakness and impaired dexterity. The initial presentation was misattributed to idiopathic Bell’s palsy, which delayed recognition of a more serious underlying condition. Neuroimaging revealed enhancement of multiple cranial nerves and diffuse leptomeningeal involvement. Cerebrospinal fluid (CSF) analysis demonstrated lymphocytic pleocytosis, elevated protein levels, low glucose, and increased lactate dehydrogenase (LDH), findings suggestive of a malignant infiltrative process. Additional imaging of the spine and plexus showed diffuse marrow signal abnormalities, cauda equina enhancement, and a right C5 nerve root mass with bony erosion. A diagnosis of stage IVA diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) and leptomeningeal involvement was established during admission. The patient was referred to hematology, and a multidisciplinary team recommended systemic chemotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix) or rituximab, ifosfamide, carboplatin, and etoposide (RICE), followed by autologous stem cell transplantation for consolidation. This case highlights a rare presentation of CNS lymphoma and underscores the importance of early consideration of malignancy in patients presenting with progressive cranial neuropathies and polyradiculopathy, particularly in the absence of constitutional or systemic symptoms. Timely neuroimaging and CSF analysis were instrumental in achieving an accurate diagnosis, allowing for early initiation of appropriate therapy in this aggressive disease.

## Linked entities

- **Chemicals:** methotrexate (PubChem CID 4112), cytarabine (PubChem CID 6253), thiotepa (PubChem CID 5453), ifosfamide (PubChem CID 3690), carboplatin (PubChem CID 426756), etoposide (PubChem CID 36462)
- **Diseases:** Bell’s palsy (MONDO:0005665), diffuse large B-cell lymphoma (MONDO:0018905)

## Full-text entities

- **Diseases:** CNS lymphoma (MESH:D008223), cranial neuropathies (MESH:D003389), lower limb weakness (MESH:D018908), idiopathic Bell's palsy (MESH:D020330), polyradiculopathy (MESH:D011128), impaired dexterity (MESH:D060825), malignancy (MESH:D009369), Facial Nerve Palsy (MESH:D005155), bony erosion (MESH:D014077), lymphocytic pleocytosis (MESH:D007964), DLBCL (MESH:D016403)
- **Chemicals:** cytarabine (MESH:D003561), ifosfamide (MESH:D007069), rituximab (MESH:D000069283), thiotepa (MESH:D013852), glucose (MESH:D005947), methotrexate (MESH:D008727), RICE (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12296357/full.md

---
Source: https://tomesphere.com/paper/PMC12296357